Protein kinase C signaling "in" and "to" the nucleus: Master kinases in transcriptional regulation

被引:6
作者
Kazanietz, Marcelo G. [1 ]
Cooke, Mariana [1 ]
机构
[1] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA
关键词
NF-KAPPA-B; PROSTATE-CANCER CELLS; ESTER-INDUCED APOPTOSIS; PROMOTES TH17 DIFFERENTIATION; PROMYELOCYTIC LEUKEMIA-CELLS; RIBOSOMAL-RNA SYNTHESIS; DELTA PKC-DELTA; PHORBOL-ESTER; DOWN-REGULATION; TRANSGENIC MICE;
D O I
10.1016/j.jbc.2024.105692
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PKC is a multifunctional family of Ser-Thr kinases widely implicated in the regulation of fundamental cellular functions, including proliferation, polarity, motility, and differentiation. Notwithstanding their primary cytoplasmic localization and stringent activation by cell surface receptors, PKC isozymes impel prominent nuclear signaling ultimately impacting gene expression. While transcriptional regulation may be wielded by nuclear PKCs, it most often relies on cytoplasmic phosphorylation events that result in nuclear shuttling of PKC downstream effectors, including transcription factors. As expected from the unique coupling of PKC isozymes to signaling effector pathways, glaring disparities in gene activation/repression are observed upon targeting individual PKC family members. Notably, specific PKCs control the expression and activation of transcription factors implicated in cell cycle/mitogenesis, epithelial-to-mesenchymal transition and immune function. Additionally, PKCs isozymes tightly regulate transcription factors involved in stepwise differentiation of pluripotent stem cells toward specific epithelial, mesenchymal, and hematopoietic cell lineages. Aberrant PKC expression and/or activation in pathological conditions, such as in cancer, leads to profound alterations in gene expression, leading to an extensive rewiring of transcriptional networks associated with mitogenesis, invasiveness, stemness, and tumor microenvironment dysregulation. In this review, we outline the current understanding of PKC signaling "in" and "to" the nucleus, with significant focus on established paradigms of PKC-mediated transcriptional control. Dissecting these complexities would allow the identification of relevant molecular targets implicated in a wide spectrum of diseases.
引用
收藏
页数:20
相关论文
共 280 条
  • [1] Protein Kinase Cα Mediates Erlotinib Resistance in Lung Cancer Cells
    Abera, Mahlet B.
    Kazanietz, Marcelo G.
    [J]. MOLECULAR PHARMACOLOGY, 2015, 87 (05) : 832 - 841
  • [2] Regulated Binding of Importin-α to Protein Kinase Cδ in Response to Apoptotic Signals Facilitates Nuclear Import
    Adwan, Tariq S.
    Ohm, Angela M.
    Jones, David N. M.
    Humphries, Michael J.
    Reyland, Mary E.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (41) : 35716 - 35724
  • [3] Affandi T, 2023, bioRxiv, DOI [10.1101/2023.05.24.541991, 10.1101/2023.05.24.541991, DOI 10.1101/2023.05.24.541991]
  • [4] Aksoy E, 2002, EUR J IMMUNOL, V32, P3040, DOI 10.1002/1521-4141(200211)32:11<3040::AID-IMMU3040>3.0.CO
  • [5] 2-M
  • [6] PLC-gamma activation is required for PDGF-beta R-mediated mitogenesis and monocytic differentiation of myeloid progenitor cells
    Alimandi, M
    Heidaran, MA
    Gutkind, JS
    Zhang, JC
    Ellmore, N
    Valius, M
    Kazlauskas, A
    Pierce, JH
    Li, WQ
    [J]. ONCOGENE, 1997, 15 (05) : 585 - 593
  • [7] THE JUN PROTO-ONCOGENE IS POSITIVELY AUTOREGULATED BY ITS PRODUCT, JUN/AP-1
    ANGEL, P
    HATTORI, K
    SMEAL, T
    KARIN, M
    [J]. CELL, 1988, 55 (05) : 875 - 885
  • [8] PHORBOL ESTER INDUCIBLE GENES CONTAIN A COMMON CIS ELEMENT RECOGNIZED BY A TPA-MODULATED TRANS-ACTING FACTOR
    ANGEL, P
    IMAGAWA, M
    CHIU, R
    STEIN, B
    IMBRA, RJ
    RAHMSDORF, HJ
    JONAT, C
    HERRLICH, P
    KARIN, M
    [J]. CELL, 1987, 49 (06) : 729 - 739
  • [9] Protein kinase c δ overexpressing transgenic mice are resistant to chemically but not to UV radiation-induced development of squamous cell carcinomas:: A possible link to specific cytokines and cyclooxygenase-2
    Aziz, MH
    Wheeler, DL
    Bhamb, B
    Verma, AK
    [J]. CANCER RESEARCH, 2006, 66 (02) : 713 - 722
  • [10] I-KAPPA-B - A SPECIFIC INHIBITOR OF THE NF-KAPPA-B TRANSCRIPTION FACTOR
    BAEUERLE, PA
    BALTIMORE, D
    [J]. SCIENCE, 1988, 242 (4878) : 540 - 546